New Jersey § 34:1b-21

§ 34:1b-21.

The Legislature finds and declares that: Millions of people suffer from currently incurable diseases and injuries, and recent

medical science, including the use of new regenerative medical therapies such as the

use of a special type of human cells called “stem cells,” provides indications that

cures and treatments for certain of these diseases and injuries can be developed; The development of such cures and treatments will improve New Jersey's health care

system, can reduce long-term health care costs, and can benefit the New Jersey economy

by creating projects, jobs and therapies; The State of New Jersey is home to many of the leading life sciences, biotechnology

and pharmaceutical companies and the State seeks to preserve its leading role, attract

investment, attract scientists, enhance research and, toward that end, seeks to finance

facilities for entities involved in stem cell research, life sciences and biomedical

research; Financing stem cell research facilities and life sciences and biomedical research

facilities will substantially further the public interest and can most economically

be financed through a bond issue; and The State of New Jersey has determined that bonds issued by the New Jersey Economic

Development Authority are the most desirable means to provide funding for such facilities

and projects.